Synthesis and characterization of 1-amidino-O-alkylureas metal complexes as α- glucosidase Inhibitors: Structure-activity relationship, molecular docking, and kinetic studies

被引:18
作者
Moghaddam, Firouz Matloubi [1 ]
Daneshfar, Maryam [1 ]
Daneshfar, Zahra [2 ]
Iraji, Aida [3 ,4 ]
Samandari-Najafabad, Atefe [5 ]
Faramarzi, Mohammad Ali [6 ]
Mahdavi, Mohammad [5 ]
机构
[1] Sharif Univ Technol, Dept Chem, Lab Organ Synth & Nat Prod, Azadi St,POB 111559516, Tehran, Iran
[2] KN Toosi Univ Technol, Fac Sci, Dept Chem, POB 15875-4416, Tehran, Iran
[3] Shiraz Univ Med Sci, Stem Cells Technol Res Ctr, Shiraz, Iran
[4] Shiraz Univ Med Sci, Cent Res Lab, Shiraz, Iran
[5] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran
[6] Univ Tehran Med Sci, Fac Pharm, Dept Pharmaceut Biotechnol, POB 14155-6451, Tehran 1417614411, Iran
基金
美国国家科学基金会;
关键词
Metformin; alpha-Glucosidase; Metal complex; Antidiabetic effects; Homology modeling; Molecular docking; TRANSITION-METAL; NI(II) COMPLEXES; CRYSTAL; COPPER(II); METFORMIN; ANTIOXIDANT; DERIVATIVES; CU(II); DRUG;
D O I
10.1016/j.molstruc.2021.131726
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
In the present study, metal complexes of 1-amidino-O-alkylureas were designed, synthesized and characterized by elemental analyses, FT-IR spectra, XRD, Mass analyses and scanning electron microscopy (SEM). All synthesized complexes were screen as alpha-Glucosidase inhibitors. According to the in vitro results, the Cu (II) complexes showed superior potency compared to other tested metal complexes. Particularly, [Cu(L-Me)(2)](Cl)(2) (1b) showed the strongest inhibition against alpha-Glucosidase with an IC50 value of 2.75 +/- 0.3 mu M which was comparable to that of acarbose (IC50 = 750 mu M). These findings are supported by the ligands and enzyme interactions through molecular docking. (C) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页数:8
相关论文
共 47 条
[1]   Synthesis and intensive characterization for novel Zn(II), Pd(II), Cr(III) and VO(II)-Schiff base complexes; DNA-interaction, DFT, drug-likeness and molecular docking studies [J].
Abu-Dief, Ahmed M. ;
El-khatib, Rafat M. ;
Aljohani, Faizah S. ;
Alzahrani, Seraj Omar ;
Mahran, Asmaa ;
Khalifa, Mohamed E. ;
El-Metwaly, Nashwa M. .
JOURNAL OF MOLECULAR STRUCTURE, 2021, 1242
[2]   FORMATION OF METFORMIN COMPLEXES WITH SOME TRANSITION-METAL IONS - THEIR BIOLOGICAL-ACTIVITY [J].
ABUELWAFA, SM ;
ELRIES, MA ;
AHMED, FH .
INORGANICA CHIMICA ACTA-BIOINORGANIC CHEMISTRY, 1987, 136 (03) :127-131
[3]   Study of chemical bonding, physical and biological effect of metformin drug as an organized medicine for diabetes patients with chromium(III) and vanadium(IV) ions [J].
Adam, Abdel Majid A. ;
Sharshar, T. ;
Mohamed, Mahmoud A. ;
Ibrahim, Omar B. ;
Refat, Moamen S. .
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2015, 149 :323-332
[4]   Synthesis, spectroscopic, and thermal investigation of transition and non-transition complexes of metformin as potential insulin-mimetic agents [J].
Al-Saif, Foziah A. ;
Refat, Moamen S. .
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2013, 111 (03) :2079-2096
[5]  
Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37
[6]  
Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S011, 10.2337/dc13-S067, 10.2337/dc11-S011, 10.2337/dc12-s011, 10.2337/dc11-S062, 10.2337/dc14-S081, 10.2337/dc10-S062, 10.2337/dc13-S011]
[7]   Novel Cu(II), Co(II) and Zn(II) metal complexes with mixed-ligand: Synthesis, crystal structure, α-glucosidase inhibition, DFT calculations, and molecular docking [J].
Avci, Davut ;
Alturk, Sumeyye ;
Sonmez, Fatih ;
Tamer, Omer ;
Basoglu, Adil ;
Atalay, Yusuf ;
Kurt, Belma Zengin ;
Dege, Necmi .
JOURNAL OF MOLECULAR STRUCTURE, 2019, 1197 :645-655
[8]  
BEGLEY MJ, 1986, J CHEM RES-S, P172
[9]  
BISCHOFF H, 1994, EUR J CLIN INVEST, V24, P3
[10]   Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
LANCET, 2002, 359 (9323) :2072-2077